Muhammet Enes Gurses’ Post

March is Brain Tumour Awareness Month💚 With brain metastasis sadly affecting approximately 20% of all patients with cancer, we know how important it is to preserve quality of life when treating cancer that has spread to the brain. That’s why at GenesisCare in the UK, we deliver a world-class specialist neuro-oncology service and our centres in London and Oxford are centres of excellence for stereotactic radiosurgery (SRS). This advanced ‘brain-sparing’ radiotherapy approach for brain tumours is recognised for its ability to preserve quality of life in people with brain metastases. To complement our SRS treatment, we offer fMRI scanning - a non-invasive MRI technique to better understand the possible outcomes of neurosurgery. As part of our patient-centred care approach, all our patients are discussed in our twice weekly national multi-disciplinary meeting which brings together UK’s leading experts, including Neuro-oncologists, Neuro-Surgeons, Neuro-radiologists, Medical Physicists and Neuro Clinical Nurse Specialists. This ensures tailored treatment plans and the best possible outcomes for all our patients. Our streamlined Rapid access SRS pathway allows appropriate patients to have SRS within just one week of the treatment decision. 👉 Find out more about our world-class neuro-oncology service we offer to UK patients here> https://bit.ly/3TIeUNw #braintumourawarenessmonth #designingbettercare

A Magnetic Helmet Shrunk a Deadly Brain Tumor in First Human Trial: Researchers successfully reduced the size of an aggressive glioblastoma tumor by more than 31% using a non-invasive magnetic helmet. The trial, conducted on a 53-year-old patient with end-stage recurrent glioblastoma, showed significant tumor shrinkage within just five weeks of treatment. Glioblastoma is one of the deadliest brain cancers in adults, with most patients surviving only a few months to two years despite conventional treatments like surgery, radiation, and chemotherapy. The innovative Oncomagnetic Device consists of three oscillators attached to a helmet connected to a microprocessor-based controller, generating an oscillating magnetic field. I nitially administered in the hospital for two hours, the treatment was continued at home with the help of the patient’s wife, gradually increasing to a maximum of six hours per day. Although the patient passed away from an unrelated injury after a month, an autopsy confirmed the rapid tumor reduction. This magnetic therapy, which was well-tolerated and correlated with dosage, offers hope for a new non-invasive and non-toxic option to treat brain cancer. Researchers are optimistic about further trials to explore its potential for widespread clinical use. #BrainCancerResearch #GlioblastomaAwareness #CancerInnovation #MedicalBreakthrough #MagneticTherapy #Oncology #NonInvasiveTreatment #CancerResearch #Neuroscience #HealthcareInnovation #FutureOfMedicine #BrainTumorAwareness #CancerTreatment #MedicalTechnology #HopeForCancerPatients

March is Brain Tumour Awareness Month💚 With brain metastasis sadly affecting approximately 20% of all patients with cancer, we know how important it is to preserve quality of life when treating cancer that has spread to the brain. That’s why at GenesisCare, we deliver a world-class specialist neuro-oncology service and our centres in London and Oxford are centres of excellence for stereotactic radiosurgery (SRS). This advanced ‘brain-sparing’ radiotherapy approach for brain tumours is recognised for its ability to preserve quality of life in people with brain metastases. To complement our SRS treatment, we offer fMRI scanning - a non-invasive MRI technique to better understand the possible outcomes of neurosurgery. As part of our patient-centred care approach, all our patients are discussed in our twice weekly national multi-disciplinary meeting which brings together UK’s leading experts, including Neuro-oncologists, Neuro-Surgeons, Neuro-radiologists, Medical Physicists and Neuro Clinical Nurse Specialists. This ensures tailored treatment plans and the best possible outcomes for all our patients. Our streamlined Rapid access SRS pathway allows appropriate patients to have SRS within just one week of the treatment decision. 👉 Find out more about our world-class neuro-oncology service here> https://bit.ly/3TIeUNw

Breaking Ground in Brain Tumor Treatment: Highlights from the British Neuro Oncology Society Annual Meeting 2024 The University of Cambridge hosted experts in neuro-oncology on July 17, 2024, showcasing advancements in brain tumor management. Key takeaways include: * - Precision radio surgery: Improved tumor targeting with breakthroughs in radio surgical techniques * - Tumor-specific chemotherapy: Novel agents and regimens targeting specific brain tumor types * - Surgical innovations: Updates on minimally invasive techniques and intraoperative imaging technologies * - Adjuvant treatments: Discussions on enhancing treatment outcomes with adjuvant therapies Experts shared experiences, presented research, and discussed future directions in neuro-oncology. #BrainTumorTreatment #NeuroOncology #MedicalBreakthroughs #Radiosurgery #Chemotherapy #SurgicalInnovations #AdjuvantTherapies #BrainTumorResearch

Fact: While all brain cancers are tumours, not all brain tumours are cancerous. In fact, only about a third of brain tumours are cancerous. But don't be so quick to dismiss this! Early detection is crucial regardless of the nature of the tumour. When left to grow unchecked, even benign tumours can impact brain function and health. In the coming month, we are dedicating it to raising awareness for brain tumours. Join us at our kick-off event to learn more about brain tumours from the experts themselves. The first 50 sign-ups get a free lunch delivered straight to them! Sign up now: https://for.sg/braingp/ Follow us for updates on what else we've planned for November! A special shoutout to the Brain Tumour Awareness Month (BTAM) committee: Dr Bala Vellayappan, Senior Consultant, Department of Radiation Oncology, National University Cancer Institute, Singapore. Asst Prof Vincent Nga, Head & Senior Consultant, Department of Surgery, National University Hospital. #TeamNCIS #NCISFightsCancer #BrainTumourAwareness #Neurology #NeuroOncology #BrainTumours

🚨 Choroid Plexus Carcinoma (CPC) 🚨 DON’T SCROLL PAST! It may sound complex, but it’s essential to know what this means: Choroid Plexus Carcinoma is a rare brain tumor that primarily affects children and can be diagnosed as early as infancy. This tumor develops in the brain's ventricles, which are fragile areas, making surgery particularly challenging.  Surgery can be intricate and is not always successful, with some cases resulting in fatal outcomes. However, there is hope! 🌟 Dr. Mark Souweidane has pioneered a groundbreaking chemotherapy treatment allowing for targeted intra-arterial delivery of medication straight to the tumor in concentrated doses. This method helps shrink the tumor with minimal systemic toxicity, and it reduces blood flow, increasing the likelihood of successful surgical removal.  👉 To learn more about CPC and the clinical trials led by Dr. Souweidane, click the link below https://lnkd.in/eHXzQVtG #weillcornell #WCM #neurosurgery #curekidsbraintumors

2024 is the third year of the Breast Cancer Trials Clinical Fellowship Program. The Program is aimed at early career researchers, who have a high-level interest in clinical research and qualifications in the disciplines of medical oncology, pathology, psychology and other supportive care specialties, radiation oncology, radiology, or surgery. Dr Tivya Kulasegaran is working on a project that will establish tools for the early detection of invasive lobular carcinoma, aiming to improve clinical practice and patient outcomes. We spoke with Dr Kulasegaran about the importance of this research: https://lnkd.in/gRMbqXh4

In Côte d'Ivoire, unity is strength in the management of central nervous system tumors in children. This study assessed the contribution of multidisciplinary team meetings to the clinical management of central nervous system tumors in children. "Landry Drogba, Grace Djonde, Esperance Broalet, Marc Gbazi, Raissa Diaby, Dominique Ndri Oka, PAEDIATRIC-15 MANAGEMENT OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS BY A NEURO-ONCOLOGY MULTIDISCIPLINARY TEAM : OUR EXPERIENCE, Neuro-Oncology Advances, Volume 5, Issue Supplement_4, November 2023, Page iv11, https://lnkd.in/eeY7pRP3 " Landry Drogba; Grace DJONDE; Esperance Broalet; Marc Gbazi #oncology #cancer #tumor #neurology #centralnervoussystem #surgery #radiotherapy #chemotherapy #childtumor #multidisciplinary

🌟 Exciting News! 🌟 I am thrilled to share my latest research on advanced prostate cancer patients and symptom relief. This study explores the impact of surgical castration on alleviating symptoms in patients, adding valuable insights to the field of urology and oncology. You can read the full article here: https://lnkd.in/db3tjKXW #Research #Urology #Oncology #ProstateCancer #SurgicalCastration #PublishedStudy

The overuse of radiotherapy and chemotherapy in low-risk patients is a rising challenge. Find out how MRI could hold the solution in this article from EMJ, covering Marcelo Wroclawski's talk at the European Association of Urology's annual congress: https://hubs.la/Q02xY9ln0 #Radiotherapy #Chemotherapy #Oncology #Cancer #Urology